Patient-Reported Outcomes Predict Mortality in Cutaneous Chronic GVHDMarch 1, 2024Mixed TopicsTransplant
FDA Removes Harmful Chemicals From Food PackagingMarch 1, 2024Mixed TopicsPediatricsBusiness of MedicineDLBCLAggressive LymphomasALLAML
‘There’s Nothing Left to Try’: Oncologists on Managing GriefFebruary 29, 2024Patient & Survivor CareMixed Topics
FDA Withdraws Melflufen Approval, but EMA Still Allows Its UseFebruary 29, 2024Multiple MyelomaPatient & Survivor Care
New Trials in Leukemia and Lymphoma: Could Your Patient Benefit?February 28, 2024PediatricsPatient & Survivor CareB Cell LymphomaCLLMixed TopicsALL
Doxorubicin Increases Breast Cancer Risk in Women With Hodgkin LymphomaFebruary 27, 2024Patient & Survivor CareHodgkin Lymphoma
Are Food Emulsifiers Associated With Increased Cancer Risk?February 23, 2024Patient & Survivor CareDLBCLAggressive LymphomasALLAMLB Cell LymphomaCLL
Democratic Lawmakers Press Pfizer on Chemotherapy Drug ShortagesFebruary 22, 2024DLBCLMixed TopicsPatient & Survivor CareAggressive LymphomasALLAMLBleeding Disorders
Unleashing Our Immune Response to Quash CancerFebruary 21, 2024Gene TherapyMixed TopicsPatient & Survivor CarePediatricsAggressive LymphomasALLAML
CAR T-Cell: Do Benefits Still Outweigh Risks?February 14, 2024Cellular TherapyMixed TopicsT Cell Lymphomas